Last 29 quarters of trend data · Healthcare · Medical - Healthcare Information Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 20.66 | 4.66 | 3.64 | 25.40 | 3.33 | — | 4.59 | 0.71 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | -20.7% | +3465.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.70 | 1.45 | 0.79 | 1.95 | 0.69 | 0.75 | 0.32 | 0.16 | 0.35 | 0.10 | 0.25 | 0.41 | 0.54 | 1.17 | 3.12 | 6.52 | 8.58 | 8.98 | — | — | — |
| — | +94.9% | +142.4% | +1141.7% | +97.2% | +667.6% | +32.6% | -61.6% | -34.6% | -91.7% | -92.2% | -93.7% | -93.7% | -86.9% | — | — | — | — | — | — | — | |
| P/B Ratio | 3.45 | 1.98 | 1.54 | 2.79 | 1.69 | 2.16 | 1.00 | 0.80 | 1.39 | 0.36 | 0.83 | 1.44 | 1.28 | 2.56 | 6.43 | 11.65 | 7.35 | 3.68 | — | — | — |
| — | -8.6% | +54.1% | +248.6% | +22.0% | +499.4% | +21.2% | -44.4% | +8.0% | -85.9% | -87.1% | -87.6% | -82.5% | -30.5% | — | — | — | — | — | — | — | |
| P/FCF | 6.07 | 2.89 | 2.29 | 4.28 | 1.87 | 6.87 | 1.35 | — | 4.48 | 0.58 | 7.13 | — | — | — | — | 28.29 | — | 54.11 | — | — | — |
| — | -57.9% | +69.7% | — | -58.3% | +1079.6% | -81.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 5.59 | 2.63 | 2.37 | 9.33 | 1.78 | 6.28 | 1.72 | 0.96 | 6.27 | 7.05 | 13.69 | — | 102.11 | 34.80 | — | 52.22 | — | 325.55 | — | — | — |
| — | -58.1% | +38.0% | +872.9% | -71.6% | -11.0% | -87.4% | — | -93.9% | -79.7% | — | — | — | -89.3% | — | — | — | — | — | — | — | |
| EV / EBIT | 6.01 | — | 2.54 | 10.89 | 1.86 | 8.31 | 1.93 | 1.01 | 32.76 | 7.74 | 17.97 | — | — | — | — | 94.14 | — | 23076.31 | — | — | — |
| — | — | +31.3% | +980.4% | -94.3% | +7.3% | -89.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.8% | 67.0% | 42.4% | 30.4% | 57.8% | 51.2% | 55.9% | 55.0% | 27.8% | 29.7% | 15.1% | 19.0% | 18.8% | 16.4% | 8.6% | 1.0% | -83.5% | 11.4% | 45.3% | 35.1% | 64.4% |
| — | +30.9% | -24.2% | -44.7% | +107.9% | +72.7% | +271.1% | +189.9% | +47.7% | +81.1% | +75.0% | +1821.4% | +122.6% | +43.2% | -81.0% | -97.2% | -229.6% | -75.3% | +113.6% | -64.9% | +126.9% | |
| Operating Margin | 31.5% | 57.8% | 37.5% | 20.4% | 48.7% | 13.8% | 34.1% | 44.3% | 12.3% | 7.0% | 2.1% | -37.5% | -1.3% | -0.6% | -7.9% | 8.5% | -1509.7% | -2.4% | 37.0% | 24.5% | 63.1% |
| — | +318.4% | +10.1% | -54.0% | +297.0% | +98.2% | +1486.5% | +218.1% | +1036.6% | +1232.0% | +127.2% | -542.8% | +99.9% | +74.1% | -121.4% | -65.4% | -2491.8% | -105.4% | +117.9% | -58.9% | +131.3% | |
| Net Margin | 8.1% | 31.2% | 21.6% | 7.8% | 20.7% | -7.3% | 6.9% | 23.9% | -11.2% | -0.5% | -0.5% | -45.4% | -8.8% | -5.9% | -9.1% | -8.2% | -1451.6% | -33.2% | 27.1% | 22.0% | 45.6% |
| — | +530.7% | +212.9% | -67.4% | +285.6% | -1415.8% | +1380.3% | +152.8% | -26.2% | +91.9% | +94.1% | -451.5% | +99.4% | +82.2% | -133.7% | -137.3% | -3283.5% | -177.1% | +112.3% | -41.9% | +116.8% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 22.6% | 12.4% | 10.8% | 2.7% | 14.3% | -5.8% | 6.1% | 43.8% | -10.9% | -0.4% | -0.5% | -34.4% | -5.2% | -3.2% | -4.5% | -3.5% | -117.9% | -6.0% | 16.3% | 10.5% | 76.2% |
| — | +314.2% | +76.2% | -93.7% | +231.7% | -1187.7% | +1441.5% | +227.5% | -108.9% | +85.9% | +89.8% | -882.8% | +95.6% | +47.1% | -127.5% | -133.2% | -254.8% | -114.9% | +490.9% | -80.5% | +203.7% | |
| ROA | 9.0% | 6.9% | 5.0% | 1.3% | 6.1% | -2.2% | 2.1% | 11.3% | -2.0% | -0.1% | -0.1% | -7.2% | -1.2% | -0.8% | -1.2% | -1.0% | -63.1% | -4.0% | 9.0% | 5.8% | 67.0% |
| — | +410.3% | +141.7% | -88.9% | +400.8% | -2406.4% | +2376.8% | +256.6% | -68.7% | +89.0% | +92.4% | -605.8% | +98.1% | +80.1% | -113.3% | -117.4% | -194.2% | -111.4% | +488.1% | -77.2% | +426.6% | |
| ROIC | 38.0% | 13.9% | 10.4% | 3.7% | 15.7% | 4.5% | 10.5% | 20.5% | 2.2% | 1.2% | 0.3% | -5.3% | -0.2% | -0.1% | -0.9% | 1.0% | -57.2% | -0.2% | 11.0% | 5.8% | 81.6% |
| — | +207.0% | -1.2% | -81.9% | +620.8% | +271.1% | +3069.0% | +486.6% | +1456.9% | +1716.3% | +135.4% | -652.6% | +99.7% | +69.7% | -108.5% | -83.3% | -170.2% | -100.8% | +696.6% | -83.3% | +550.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.83 | 0.51 | 0.79 | 0.83 | 0.89 | 1.02 | 1.24 | 1.69 | 3.80 | 3.52 | 3.40 | 3.49 | 3.12 | 2.65 | 2.57 | 2.22 | 1.97 | 0.44 | 0.06 | 0.93 | 0.04 |
| — | -50.3% | -36.4% | -50.8% | -76.6% | -70.9% | -63.5% | -51.6% | +21.7% | +32.7% | +32.3% | +57.0% | +58.3% | +507.5% | +3958.1% | +138.3% | +4472.0% | +787.7% | +67.4% | -8.5% | -97.6% | |
| Debt / EBITDA | 1.19 | 2.49 | 4.02 | 9.73 | 2.87 | 8.87 | 4.42 | 2.85 | 20.72 | 29.36 | 48.33 | — | 307.29 | 75.22 | — | 34.15 | — | 140.91 | 0.14 | 10.59 | 0.04 |
| — | -71.9% | -8.9% | +241.7% | -86.1% | -69.8% | -90.9% | — | -93.3% | -61.0% | — | — | — | -46.6% | — | +222.4% | — | +134325.9% | — | +359.0% | — | |
| Current Ratio | 3.41 | 5.00 | 3.14 | 3.41 | 3.20 | 2.43 | 2.27 | 2.08 | 1.77 | 1.59 | 1.68 | 1.56 | 1.34 | 1.60 | 1.85 | 1.79 | 2.45 | 2.64 | 1.78 | 4.09 | 1.78 |
| — | +105.8% | +38.2% | +64.3% | +80.2% | +52.8% | +35.7% | +33.3% | +32.7% | -0.9% | -9.5% | -12.8% | -45.6% | -39.2% | +4.3% | -56.3% | +38.1% | +243.9% | +196.5% | -5.2% | +2682.1% | |
| Quick Ratio | 3.39 | 4.96 | 3.12 | 3.39 | 3.18 | 2.42 | 2.26 | 2.06 | 1.74 | 1.55 | 1.63 | 1.50 | 1.30 | 1.56 | 1.78 | 1.72 | 2.38 | 2.59 | 1.78 | 4.01 | 1.78 |
| — | +105.3% | +38.2% | +65.1% | +82.7% | +55.8% | +38.8% | +37.1% | +34.3% | -0.6% | -8.6% | -12.9% | -45.6% | -39.7% | +0.2% | -57.1% | +34.0% | +237.2% | +196.5% | -5.7% | +2682.1% | |
| Interest Coverage | 12.01 | 26.06 | 17.35 | 6.21 | 23.73 | 5.18 | 11.26 | 22.49 | 0.52 | 1.77 | 0.97 | -6.25 | -0.19 | -0.05 | -1.49 | 1.52 | -125.80 | 0.01 | 14.47 | 9.82 | 60.47 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 29 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NUTX stock.
Nutex Health, Inc.'s current P/E is 20.7x. The average P/E over the last 4 quarters is 9.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Nutex Health, Inc.'s current operating margin is 31.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Nutex Health, Inc.'s business trajectory between earnings reports.